PODD vs BIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 23, 2026

PODD

55.8
AI Score
VS
PODD Wins

BIO

55.3
AI Score

Investment Advisor Scores

PODD

56score
Recommendation
HOLD

BIO

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PODD BIO Winner
Revenue 358.10M 1.24B BIO
Net Income 23.80M -155.70M PODD
Gross Margin 67.2% 52.7% PODD
Net Margin 6.6% -12.5% PODD
Operating Income 27.70M 106.70M BIO
ROE 4.7% -2.2% PODD
ROA 1.0% -1.5% PODD
Total Assets 2.29B 10.25B BIO
Debt/Equity 2.78 0.17 BIO
Current Ratio 3.47 3.14 PODD
Free Cash Flow -10.00M 144.80M BIO

Relative Price Performance (Last 90 Days)

PODD 1M: -11.1% · 3M: -17.6% BIO 1M: -5.0% · 3M: +25.1%

Current Technical Phase

PODD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 36

RSI (14): 35.9 · Price: $131.69

BIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.4 · Price: $369.14

Fundamentals Snapshot

Metric PODD BIO
Market Cap — —
Forward P/E 17.1 37.2
Trailing P/E 24.6 43.4
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.7% 0.5%
Operating Margin 0.2% 0.1%
EPS 5.32 8.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PODD is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.